Does infusion of ANG II increase muscle sympathetic nerve activity in patients with primary aldosteronism?

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 6, 2008, Pages

  Matsukawa, Toshiyoshi ^a   Miyamoto, Takenori ^a  

^a JAPAN WOMEN'S UNIVERSITY   (Japan)

Author keywords

Angiotensin II

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; RENIN; SODIUM; ADRENERGIC RECEPTOR STIMULATING AGENT;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HUMAN; HYPERTENSION; MALE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BLOOD LEVEL; SYMPATHETIC NERVE; ADRENALECTOMY; ADRENERGIC SYSTEM; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; HEART RATE; HYPERALDOSTERONISM; INNERVATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSORECEPTOR REFLEX; SKELETAL MUSCLE;

ADRENALECTOMY; ADULT; ALDOSTERONE; ANGIOTENSIN II; BAROREFLEX; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NITROPRUSSIDE; PHENYLEPHRINE; RENIN; RENIN-ANGIOTENSIN SYSTEM; SODIUM; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS;

EID: 47549094681     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00471.2007     Document Type: Article

References (37)

1. Bravo EL, Tarazi RC, Dustan HP, Fouad FM. The sympathetic nervous system and hypertension in primary aldosteronism. Hypertension 7: 90-96, 1985.
2. DeChamplain J, Krafoff LR, Axelrod J. Interrelationships of sodium intake, hypertension and norepinephrine storage in the rat. Circ Res 24, Suppl 1: I75-I92, 1969.
3. Dendorfer A, Thornagel A, Raasch W, Grisk O, Tempel K, Dominiak P. Angiotensin II induces catecholamine release by direct ganglionic excitation. Hypertension 40: 348-354, 2002.
4. Gomes-Sanchez EP. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 118: 819-823, 1986.
5. Gomes-Sanchez EP, Fort CM, Gomes-Sanchez CE. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension. Am J Physiol Endocrinol Metab 258: E482-E484, 1990.
6. Guo GB, Thames MD, Abboud FM. Arterial baroreflexes in renal hypertensive rabbits. Circ Res 53: 223-234, 1983.
7. Gustkin JS, Kurihara M, Saavedra JM. Increased angiotensin II receptors in brain nuclei of DOCA-rats hypertensive rats. Am J Physiol Heart Circ Physiol 255: H646-H650, 1988.
8. Horky K, Kopecka J, Widimsky J Jr, Gregorva I, Tesar P. Urinary excretion of catecholamines in patients with primary aldosteronism before and after unilateral adrenalectomy. Cor Vasa 25: 401-412, 1983.
9. Izzo JL Jr, Horwitz D, Lawton WJ, Keiser HR. Fuldrocortisone suppression of sympathetic nervous activity. Clin Pharmacol Ther 33: 102-106, 1983.
10. Ma X, Chapleau MW, Whiteis CA, Abboud FM, Bielefeldt K. Angiotensin selectively activates a subpopulation of postganglionic sympathetic neurons in mice. Circ Res 88: 787-793, 2001.
11. Ma X, Sigmund CD, Hingtgen SD, Tian X, Davisson RL, Abboud FM, Chapleau MW. Ganglionic action of angiotensin contributes to sympathetic activity in renin-angiotensinogen transgenic mice. Hypertension 43: 312-316, 2004.
12. Matsukawa T, Gotoh E, Hasegawa O, Shionoiri H, Tochikubo O, Ishii M. Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertension. J Hypertens 9: 537-542, 1991.
13. Matsukawa T, Gotoh E, Minamisawa K, Kihara M, Ueda S, Shionoiri H, Ishii M. Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am J Phsiol Regul Integr Comp Physiol 261: R690-R696, 1991.
14. Matsukawa T, Mano T. Atrial natriuretic hormone inhibits angiotensin II-stimulated sympathetic nerve activity in humans. Am J Phsiol Regul Integr Comp Physiol 271: R464-R471, 1996.
15. Matsukawa T, Mano T, Gotoh E, Ishii M. Elevated sympathetic nerve activity in patients with accelerated hypertension. J Clin Invest 92: 25-28, 1993.
16. Matsukawa T, Sugiyama Y, Mano T. Age-related changes in baroreflex control of heart rate and sympathetic nerve activity in healthy humans. J Auton Nerv Syst 60: 209-212, 1996.
17. May CN. Differential regional haemodynamic changes during mineralocorticoid hypertension. J Hypertens 24: 1137-1146, 2006.
18. Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shionoiri H, Tochikubo O, Ishii M. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronisms. Hypertension 17: 1057-1062, 1991.
19. Monahan KD, Leuenberger UA, Ray CA. Aldosterone impaired baroreflex sensitivity in healthy adults. Am J Physiol Heart Circ Physiol 292: H190-H197, 2007.
20. Munakata M, Imai Y, Hashimoto J, Omata K, Nakao M, Yamamoto M, Abe K. Normal sympathetic vasomotor and cardiac parasympathetic activities in patients with primary aldosteronism: assessment by spectral. J Auton Nerv Syst 52: 213-223, 1995.
21. Nicholls MG, Espiner EA, Miles KD, Zweifler AJ, Julius S. Evidence against an interaction of angiotensin II with the sympathetic nervous system in man. Clin Endoclinol 15: 423-430, 1981.
22. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: converting signals for neurogenic hypertension. Curr Hypertens Rep 9: 228-235, 2007.
23. Penington GL, Mckinley MJ. Reduction of cerebral NaCl concentration can abolish mineralocorticoid escape. Am J Physiol Renal Fluid Electrolyte Physiol 259: F839-F846, 1990.
24. Phillips MI. Functions of angiotensin in the central nervous system. Annu Rev Physiol 49: 413-435, 1987.
25. Pickering TG, Gribbin B, Petersen ES, Cunningham DJ, Sleight P. Effects of autonomic blockade on the baroreflex in man at rest and during exercise. Circ Res 30:177-185, 1972.
26. Pirpiris M, Cox H, Esler M, Jennings GL, Whitworth JA. Mineralocorticoid induced hypertension and noradrenaline spillover in man. Clin and Exper Hypertension 16: 147-161, 1994.
27. Ramsy DJ. Effects of circulating angiotensin II on the brain. In: Frontiers in Neuroendocrinology, edited by Ganong WF and Martini L. New York: Raven, 1982, p. 263-285.
28. Reid IA. Actions of angiotensin II on the brain: mechanisms and physiological role. Am J Physiol Renal Fluid Electrolyte Physiol 246: F533-F543, 1984.
29. Reid JL, Zivin JA, Kopin IJ. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats. Circ Res 37: 569-579, 1975.
30. Ricksten SE, Thoren P. Reflex control of sympathetic nerve activity and heart rate from arterial baroreceptors in conscious spontaneously hypertensive rats. Clin Sci 61: S169-S172, 1981.
31. Schifferin EL, Franks DJ, Genest J. Effect of aldosterone on vascular angiotensin II receptors in the rat. Can J Physiol Pharmacol 63: 1522-1527, 1985.
32. Schifferin EL, Gutkowska J, Genest J. Effect of angiotensin II and deoxycorticosterone infusion on vascular angiotensin II receptors in rats. Am J Physiol Heart Circ Physiol 246: H608-H614, 1984.
33. Schmidt BMW, Horisberger K, Feuring M, Schultz A, Wehling M. Aldosterone blunts human baroreflex sensitivity by a nongenomic mechanism. Exp Clin Endocrinol Diabetes 113: 252-256, 2005.
34. Shelat SG, King JL, Flanagan-Cato LM, Fluhantly SJ. Mineralocorticoids and glucocorticoids cooperatively increase salt intake and angiotensin II receptor binding in rat brain. Neuroendocrinology 69: 339-351, 1999.
35. Sosa Leon LA, McKinley MJ, McAllen RM, May CN. Aldosterone acts on the kidney, not the brain, to cause mineralocorticoid hypertension in sheep. J Hypertens 20: 1203-1208, 2002.
36. Veelken R, Hilgers KF, Ditting T, Leonard M, Mann JF, Geiger H, Luft FC. Impaired cardiovascular reflexes precede deoxycorticosterone acetate-salt hypertension. Hypertension 24: 564-570, 1994.
37. Wilson KM, Sumners Colin Hathaway S, Fregley M. Mineralocorticoids modulate central angiotensin II receptors in rats. Brain Res 382: 87-96, 1986.